Latest articles

Bishkek hosts regional symposium on tuberculosis

Bishkek hosts regional symposium on tuberculosis

Bishkek hosts a regional symposium on tuberculosis. The symposium is held under the motto "To treat a patient, not a disease: a person-centered approach” and focuses on medical needs and expectations of people with tuberculosis. The symposium will present evidence of the effectiveness of new, shorter treatment regimens, the press service of the Kyrgyz Ministry of Health reported.

The press service of the Ministry added that the symposium will bring together international and national experts to combat the threat of tuberculosis in Eastern Europe and Central Asia.

Tuberculosis remains a serious public health problem in Eastern Europe and Central Asia, and the main themes of the regional symposium that takes place on March 1 and 2 in Bishkek will be the most modern approaches to the treatment of this disease, as well as the expansion of the use of new drugs and diagnostic tools. The scientific forum, organized jointly with the Ministry of Health of the Kyrgyz Republic and the international medical humanitarian organization Médecins Sans Frontières (MSF), brought together about 160 participants from the region and international experts.

"The Kyrgyz Republic has already accumulated experience in the introduction of new treatment regimens for tuberculosis and the patient-centered approach, as well as new financing mechanisms in the TB service," said Amangeldi Murzaliyev, Deputy Minister of Health of the Kyrgyz Republic. "Thanks to this, the TB situation in our country is improving every year."

According to data of the World Health Organization, tuberculosis is one of the top ten causes of death worldwide. In 2016, the disease claimed the lives of 1.7 million people, including 250,000 children. The overwhelming majority of these deaths occurred in low- and middle-income countries. Forms of tuberculosis resistant to major antituberculosis drugs pose an even more dangerous threat: only half of patients with multidrug-resistant tuberculosis are successfully cured.

Original url :